Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

Metformin in breast cancer: time for action.

Goodwin PJ, Ligibel JA, Stambolic V.

J Clin Oncol. 2009 Jul 10;27(20):3271-3. doi: 10.1200/JCO.2009.22.1630. Epub 2009 Jun 1. No abstract available.

PMID:
19487373
2.

Metformin as an addition to conventional chemotherapy in breast cancer.

Grenader T, Goldberg A, Shavit L.

J Clin Oncol. 2009 Dec 10;27(35):e259; author reply e260. doi: 10.1200/JCO.2009.25.4110. Epub 2009 Nov 2. No abstract available.

PMID:
19884518
3.

Metformin, B(12), and enhanced breast cancer response to chemotherapy.

Garcia A, Tisman G.

J Clin Oncol. 2010 Jan 10;28(2):e19; author reply e20. doi: 10.1200/JCO.2009.25.7857. Epub 2009 Nov 30. No abstract available.

PMID:
19949002
4.

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer.

Jiralerspong S, Palla SL, Giordano SH, Meric-Bernstam F, Liedtke C, Barnett CM, Hsu L, Hung MC, Hortobagyi GN, Gonzalez-Angulo AM.

J Clin Oncol. 2009 Jul 10;27(20):3297-302. doi: 10.1200/JCO.2009.19.6410. Epub 2009 Jun 1.

5.

Cracking open window of opportunity trials.

Kalinsky K, Hershman DL.

J Clin Oncol. 2012 Jul 20;30(21):2573-5. doi: 10.1200/JCO.2012.42.3293. Epub 2012 May 7. No abstract available.

PMID:
22565006
6.

Evolution of breast cancer management: focus on neoadjuvant chemotherapy.

Heys SD.

Breast Cancer. 2001;8(4):339-50. Review. No abstract available.

PMID:
11791128
7.

Is it the time for metformin to take place in adjuvant treatment of Her-2 positive breast cancer? Teaching new tricks to old dogs.

Yurekli BS, Karaca B, Cetinkalp S, Uslu R.

Med Hypotheses. 2009 Oct;73(4):606-7. doi: 10.1016/j.mehy.2009.05.027. Epub 2009 Jun 27.

PMID:
19560877
8.

Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor?

Stambolic V, Woodgett JR, Fantus IG, Pritchard KI, Goodwin PJ.

Breast Cancer Res Treat. 2009 Mar;114(2):387-9. doi: 10.1007/s10549-008-0015-4. Epub 2008 Apr 26. Review. No abstract available.

PMID:
18438706
9.

Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark.

Bosco JL, Antonsen S, Sørensen HT, Pedersen L, Lash TL.

Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):101-11. doi: 10.1158/1055-9965.EPI-10-0817. Epub 2010 Nov 30.

10.

Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents.

Goodwin PJ, Stambolic V, Lemieux J, Chen BE, Parulekar WR, Gelmon KA, Hershman DL, Hobday TJ, Ligibel JA, Mayer IA, Pritchard KI, Whelan TJ, Rastogi P, Shepherd LE.

Breast Cancer Res Treat. 2011 Feb;126(1):215-20. doi: 10.1007/s10549-010-1224-1. Epub 2010 Oct 26. Review.

PMID:
20976543
11.
12.

[Results of treatment of adult diabetes mellitus with Metformin-sulfonamide combination (apropos of 197 cases)].

Debry G, Laurent J.

J Med Lyon. 1966 Mar 5;47(94):407-13. French. No abstract available.

PMID:
5909923
13.

Preoperative chemotherapy for breast cancer: do we need to redefine our end points?

Breslin TM.

Ann Surg Oncol. 2003 Aug;10(7):716-7. No abstract available.

PMID:
12900360
14.

Is it time to test metformin in breast cancer prevention trials? A reply to the authors.

Barba M, Muti P.

Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2565; author reply 2565. doi: 10.1158/1055-9965.EPI-09-0515. No abstract available.

15.

Metformin/Repaglinide (PrandiMet) for type 2 diabetes.

[No authors listed]

Med Lett Drugs Ther. 2009 Jun 1;51(1313):41-3. No abstract available.

PMID:
19478691
16.

Metformin: "Old warrior for a new battle".

Jain A.

Indian J Cancer. 2010 Oct-Dec;47(4):471-2. doi: 10.4103/0019-509X.73553. No abstract available.

17.

Metformin: a diabetes drug for cancer, or a cancer drug for diabetics?

Martin M, Marais R.

J Clin Oncol. 2012 Jul 20;30(21):2698-700. doi: 10.1200/JCO.2012.42.1677. Epub 2012 May 7. No abstract available.

PMID:
22565000
18.

Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model.

Hadad SM, Appleyard V, Thompson AM.

Breast Cancer Res Treat. 2009 Mar;114(2):391. doi: 10.1007/s10549-008-0016-3. Epub 2008 Apr 18. No abstract available.

PMID:
18421577
19.

[HbA1c 8.5% in elderly people with diabetes: is it good enough?].

Bottermann P.

MMW Fortschr Med. 2009 Jun 25;151(26-29):38-9. Review. German. No abstract available.

PMID:
19739547
20.

Efficacy of metformin in the treatment of diabetes mellitus complicating thalassemia major.

Dhouib N, Turki Z, Mellouli F, Ouederni M, Yahiaoui S, Nagi S, Ben Slama C, Bejaoui M.

Tunis Med. 2010 Feb;88(2):136. No abstract available.

Supplemental Content

Support Center